Filing Details
- Accession Number:
- 0001209191-15-019812
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-27 18:01:13
- Reporting Period:
- 2015-02-20
- Filing Date:
- 2015-02-27
- Accepted Time:
- 2015-02-27 18:01:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc., 4131 Parklake Avenue, Suite 225 Raleigh NC 27612 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-20 | 140,000 | $0.00 | 1,059,800 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-02-22 | 96,837 | $0.00 | 1,156,637 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-25 | 94,000 | $14.25 | 1,062,637 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2015-02-20 | 140,000 | $0.00 | 140,000 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2015-02-22 | 96,837 | $0.00 | 96,837 | $0.00 |
| Common Stock | Restricted Stock Units | Acquisiton | 2015-02-23 | 800,000 | $0.00 | 800,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 140,000 | 2015-02-20 | 2016-02-20 | No | 4 | M | Direct |
| 193,674 | 2015-02-22 | 2017-02-22 | No | 4 | M | Direct |
| 800,000 | 2018-02-23 | No | 4 | A | Direct |
Footnotes
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of 140,000 Restricted Stock Units ("RSUs") granted to the Reporting Person on February 20, 2013 under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs under this grant will vest on February 20, 2016.
- The shares of common stock were acquired by the Reporting Person as a result of the vesting of one-third of the RSUs granted to the Reporting Person on February 22, 2014 under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs under this grant will vest on each of, (i) February 22, 2016 and (ii) February 22, 2017.
- The shares of common stock were sold under a pre-planned 10b5-1 trading plan, and were sold to cover the Reporting Person's tax liability upon the vesting of RSUs.
- On February 25, 2015, the Reporting Person sold an aggregate of 94,000 shares of the Issuer's Common Stock at a weighted average price of $14.25. The highest sale price for the Common Stock was $14.62 per share and the lowest sale price was $13.90 per share. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The RSUs were issued to the Reporting Person on February 23, 2015, pursuant to a grant under the Issuer's 2011 Equity Incentive Plan, as amended. One-third of the RSUs will vest on each of, (i) February 23, 2016, (ii) February 23, 2017 and (iii) February 23, 2018. Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
Billionaire Hedge Funds
